Author details

Full Name

Erwin G Van Meir

Affiliation

Heersink School of Medicine, University of Alabama at Birmingham

ORCID

Career Start Year

1984

Papers

189

H Index

Expertise

CM4AI Collaborator

Antoine Forget (CM4AI)

PMID	Paper Title	Journal Title	Published Year
37337931	Generation and initial characterization of mice lacking full-length BAI3 (ADGRB3) expression.	Basic Clin Pharmacol Toxicol	2023
37337931	Generation and initial characterization of mice lacking full-length BAI3 (ADGRB3) expression.	Basic Clin Pharmacol Toxicol	2023
35114205	Mice lacking full length Adgrb1 (Bai1) exhibit social deficits, increased seizure susceptibility, and altered brain development.	Exp Neurol	2022
36131014	Failure of human rhombic lip differentiation underlies medulloblastoma formation.	Nature	2022
36446943	Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.	Nature	2022
35114205	Mice lacking full length Adgrb1 (Bai1) exhibit social deficits, increased seizure susceptibility, and altered brain development.	Exp Neurol	2022
36446943	Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.	Nature	2022
36131014	Failure of human rhombic lip differentiation underlies medulloblastoma formation.	Nature	2022
34218269	Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth.	Oncogene	2021
33741928	The transcriptional landscape of Shh medulloblastoma.	Nat Commun	2021
34218269	Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth.	Oncogene	2021
33720050	N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.	J Clin Invest	2021
33926529	Ten-eleven translocation protein 1 modulates medulloblastoma progression.	Genome Biol	2021
34409497	Subgroup and subtype-specific outcomes in adult medulloblastoma.	Acta Neuropathol	2021
34409295	Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis.	Neurooncol Adv	2021
33720050	N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.	J Clin Invest	2021
33741928	The transcriptional landscape of Shh medulloblastoma.	Nat Commun	2021
33926529	Ten-eleven translocation protein 1 modulates medulloblastoma progression.	Genome Biol	2021
34409497	Subgroup and subtype-specific outcomes in adult medulloblastoma.	Acta Neuropathol	2021
34409295	Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis.	Neurooncol Adv	2021
31582835	EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.	Oncogene	2020
31969339	A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.	Clin Cancer Res	2020
31582835	EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.	Oncogene	2020
31676871	Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.	Oncogene	2020
32923515	The advent of precision epigenetics for medulloblastoma.	Oncoscience	2020
32743560	Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.	Cell Rep Med	2020
31969339	A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.	Clin Cancer Res	2020
31676871	Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.	Oncogene	2020
32743560	Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.	Cell Rep Med	2020
32923515	The advent of precision epigenetics for medulloblastoma.	Oncoscience	2020
30563937	Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.	Clin Cancer Res	2019
31748746	Longitudinal molecular trajectories of diffuse glioma in adults.	Nature	2019
31664194	Recurrent noncoding U1Â snRNA mutations drive cryptic splicing in SHH medulloblastoma.	Nature	2019
30563937	Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.	Clin Cancer Res	2019
30872606	A simple genotyping method to detect small CRISPR-Cas9 induced indels by agarose gel electrophoresis.	Sci Rep	2019
31168816	The expanding functional roles and signaling mechanisms of adhesion G protein-coupled receptors.	Ann N Y Acad Sci	2019
31748746	Longitudinal molecular trajectories of diffuse glioma in adults.	Nature	2019
31664194	Recurrent noncoding U1Â snRNA mutations drive cryptic splicing in SHH medulloblastoma.	Nature	2019
31168816	The expanding functional roles and signaling mechanisms of adhesion G protein-coupled receptors.	Ann N Y Acad Sci	2019
30872606	A simple genotyping method to detect small CRISPR-Cas9 induced indels by agarose gel electrophoresis.	Sci Rep	2019
29500331	Taking a HIF pill for old age diseases?	Aging (Albany NY)	2018
30171048	Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.	Clin Cancer Res	2018
29894688	BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.	Cancer Cell	2018
29500331	Taking a HIF pill for old age diseases?	Aging (Albany NY)	2018
30171048	Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.	Clin Cancer Res	2018
29894688	BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.	Cancer Cell	2018
27852701	BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy.	Clin Cancer Res	2017
28766956	Design and synthesis of benzopyran-based inhibitors of the hypoxia-inducible factor-1 pathway with improved water solubility.	J Enzyme Inhib Med Chem	2017
28966947	Purifying Properly Folded Cysteine-rich, Zinc Finger Containing Recombinant Proteins for Structural Drug Targeting Studies: the CH1 Domain of p300 as a Case Example.	Bio Protoc	2017
28609654	Intertumoral Heterogeneity within Medulloblastoma Subgroups.	Cancer Cell	2017

1 - 50 of 378

Olivia Singh

Princess Margaret Cancer Centre

Career Start Year 2016

Number of shared co-authors 12

Chitra Venugopal

McMaster Stem Cell and Cancer Research Institute

Career Start Year 2006

Number of shared co-authors 21

Catherine P Langford

University of Alabama at Birmingham

Career Start Year 2005

Number of shared co-authors 3

Adam M Sonabend

Northwestern University

Career Start Year 2005

Number of shared co-authors 13

Khatri Latha

Baylor College of Medicine

Career Start Year 2005

Number of shared co-authors 9

Anita B Hjelmeland

University of Alabama at Birmingham

Career Start Year 2004

Number of shared co-authors 6

Annette Bakker

Children's Tumor Foundation

Career Start Year 2004

Number of shared co-authors 4

Bo Hu

Northwestern University Feinberg School of Medicine

Career Start Year 2003

Number of shared co-authors 7

Matthias Preusser

Medical University of Vienna

Career Start Year 2003

Number of shared co-authors 44

Massimo Squatrito

Seve Ballesteros Foundation Brain Tumor group

Career Start Year 2002

Number of shared co-authors 20

Sheila K Singh

McMaster University

Career Start Year 2001

Number of shared co-authors 50

Jeongwu Lee

Lerner Research Institute, Cleveland Clinic

Career Start Year 2001

Number of shared co-authors 15

Agnieszka Bronisz

Mossakowski Medical Research Institute, Polish Academy of Sciences

Career Start Year 1999

Number of shared co-authors 4

Yuhui Yang

Xuanwu Hospital, Capital Medical University

Career Start Year 1999

Number of shared co-authors 10

Krishna P Bhat

Department of Neurosurgery at the University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 23

Ian D Clarke

Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children

Career Start Year 1997

Number of shared co-authors 51

Vinay K Puduvalli

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 19

Shi-Yuan Cheng

Northwestern University Feinberg School of Medicine

Career Start Year 1996

Number of shared co-authors 12

Kan V Lu

Clinical Medical Research Center of Hepatic Surgery at Hubei Province

Career Start Year 1995

Number of shared co-authors 9

Paul S Mischel

Stanford University

Career Start Year 1994

Number of shared co-authors 36

Frank B Furnari

University of California San Diego

Career Start Year 1992

Number of shared co-authors 28

Richard J Gilbertson

Cancer Research UK Cambridge Institute, University of Cambridge

Career Start Year 1992

Number of shared co-authors 80

Seiji Kondo

Fukuoka University

Career Start Year 1992

Number of shared co-authors 4

Donald M O'Rourke

Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania

Career Start Year 1991

Number of shared co-authors 6

Howard A Fine

Meyer Cancer Center

Career Start Year 1990

Number of shared co-authors 15

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Career Start Year 1990

Number of shared co-authors 16

Candelaria Gomez-Manzano

The University of Texas M.D. Anderson Cancer Center

Career Start Year 1990

Number of shared co-authors 17

Motoo Nagane

Kyorin University Faculty of Medicine

Career Start Year 1988

Number of shared co-authors 11

Frederick F Lang

The University of Texas M.D. Anderson Cancer Center